← Back to Search

Epidural Steroids for Back Pain

Phase 3
Recruiting
Research Sponsored by Hospital for Special Surgery, New York
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients scheduled to undergo 1 to 2 level laminectomy
Between the ages of 18-85
Must not have
Minimally invasive surgery
Non-English speakers
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 month
Awards & highlights
Pivotal Trial

Summary

This trial tests if applying a steroid during back surgery helps patients recover faster and need less pain medication. It focuses on patients having a specific type of back surgery and looks at their recovery and pain levels.

Who is the study for?
This trial is for adults aged 18-85 undergoing a specific back surgery called lumbar laminectomy. It's not for those who don't speak English, have had daily opioid use in the last six months, need additional spine procedures, have chronic pain conditions, uncontrolled diabetes (A1C > 6.5), weakened immune systems, prostate issues causing urinary problems or are allergic to Depo-Medrol and steroids.
What is being tested?
The study tests if applying Depo-Medrol steroid directly to the spinal area during surgery can reduce post-surgery opioid use and improve recovery outcomes like hospital stay duration and return-to-work time compared to a placebo (no active medication).
What are the potential side effects?
Potential side effects of Depo-Medrol may include increased blood sugar levels, risk of infection due to immune system suppression, mood swings, weight gain around the face or abdomen, insomnia and potential increase in blood pressure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am scheduled for a surgery to remove part of one or two vertebrae.
Select...
I am between 18 and 85 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I had or will have surgery with small incisions.
Select...
I do not speak English.
Select...
I am undergoing or have undergone a spinal fusion or revision at the same level.
Select...
I have a long-term pain condition.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 month for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Opioid consumption [Both Groups]
Opioid use total [Both Groups]
Secondary study objectives
Medical Complications [Both Groups]
Numeric Rating Pain Scale [Both Groups]
Oswestry Low Back Pain Disability Questionnaire [Both Groups]
+3 more

Awards & Highlights

Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Group 1: Topical SteroidExperimental Treatment1 Intervention
Group II: Group 2: Topical Normal SalinePlacebo Group1 Intervention

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Intra-operative topical epidural steroids, such as dexamethasone or methylprednisolone, are commonly used to manage postoperative pain by reducing inflammation and pain at the surgical site. These steroids work by inhibiting the release of inflammatory mediators and reducing the activity of immune cells that contribute to inflammation. This mechanism is crucial for postoperative pain patients as it helps to minimize pain, reduce the need for opioid analgesics, and promote faster recovery. Additionally, other treatments like nonsteroidal anti-inflammatory drugs (NSAIDs) and local anesthetics may be used to provide further pain relief by blocking pain signals and reducing inflammation.
Advances in topical analgesics.

Find a Location

Who is running the clinical trial?

Hospital for Special Surgery, New YorkLead Sponsor
250 Previous Clinical Trials
61,186 Total Patients Enrolled

Media Library

Depo-Medrol 40Mg/Ml Suspension for Injection Clinical Trial Eligibility Overview. Trial Name: NCT05058287 — Phase 3
Opioid Use Disorder Research Study Groups: Group 1: Topical Steroid, Group 2: Topical Normal Saline
Opioid Use Disorder Clinical Trial 2023: Depo-Medrol 40Mg/Ml Suspension for Injection Highlights & Side Effects. Trial Name: NCT05058287 — Phase 3
Depo-Medrol 40Mg/Ml Suspension for Injection 2023 Treatment Timeline for Medical Study. Trial Name: NCT05058287 — Phase 3
~0 spots leftby Dec 2024